arginine has been researched along with Leukemia P388 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blunt, J; Butler, A; Han, A; Haygood, M; Munro, M; Sandy, M | 1 |
| Dissen, E; Fossum, S; Hoelsbrekken, SE; Saether, PC | 1 |
| Mayer, MP; Melchers, I; Roth, S; Rzepka, R; Willcox, N | 1 |
| Drapier, JC; Hirling, H; Kaldy, P; Kühn, LC; Wietzerbin, J | 1 |
| Inokuchi, N; Irie, M; Itagaki, T; Iwama, M; Kobayashi, H; Ogawa, Y; Ohgi, K; Tsuji, T | 1 |
| Alberts, DS; Dorr, RT | 1 |
| Bigioni, M; Capranico, G; De Isabella, P; Tinelli, S; Zunino, F | 1 |
| Bugat, R; Canal, P; Chatelut, E; Chevreau, C; de Forni, M; Houin, G; Johnson, NP; Plusquellec, Y; Roche, H | 1 |
| Binaschi, M; Capranico, G; De Isabella, P; Tinelli, S; Zunino, F | 1 |
| Capranico, G; Kohn, KW; Pommier, Y; Zunino, F | 1 |
1 trial(s) available for arginine and Leukemia P388
| Article | Year |
|---|---|
Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Drug Synergism; Etoposide; Female; Humans; Injections, Intraperitoneal; Leukemia P388; Leukopenia; Male; Mice; Middle Aged; Peritoneal Neoplasms; Podophyllotoxin; Remission Induction; Teniposide | 1991 |
9 other study(ies) available for arginine and Leukemia P388
| Article | Year |
|---|---|
Vanchrobactin and anguibactin siderophores produced by Vibrio sp. DS40M4.
Topics: Animals; Antineoplastic Agents; Arginine; Drug Screening Assays, Antitumor; Leukemia P388; Marine Biology; Mice; Molecular Structure; Peptides; Serine; Siderophores; Vibrio | 2010 |
Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Arginine; Cell Line; Cell Line, Tumor; Cytotoxicity, Immunologic; Dimerization; HEK293 Cells; Humans; Killer Cells, Natural; Leukemia P388; Lysine; Mice; Molecular Sequence Data; Mutation; NK Cell Lectin-Like Receptor Subfamily C; NK Cell Lectin-Like Receptor Subfamily D; Protein Binding; Rats; Receptors, Immunologic | 2011 |
Major differences in antigen-processing correlate with a single Arg71<-->Lys substitution in HLA-DR molecules predisposing to rheumatoid arthritis and with their selective interactions with 70-kDa heat shock protein chaperones.
Topics: Amino Acid Substitution; Animals; Antigen Presentation; Arginine; Arthritis, Rheumatoid; Clone Cells; Epitopes, T-Lymphocyte; Escherichia coli Proteins; Genetic Predisposition to Disease; HLA-DR Antigens; HSP70 Heat-Shock Proteins; Humans; Hybridomas; Leukemia P388; Lysine; Mice; Protein Subunits; Receptors, Cholinergic; Recombinant Proteins; T-Lymphocytes; Transfection; Tumor Cells, Cultured | 2002 |
Reciprocal modulation of aconitase activity and RNA-binding activity of iron regulatory factor by nitric oxide.
Topics: Aconitate Hydratase; Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Interferon-gamma; Iron-Regulatory Proteins; Leukemia P388; Lipopolysaccharides; Macrophages; Mice; Molsidomine; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Recombinant Proteins; RNA-Binding Proteins; RNA, Messenger; Tumor Cells, Cultured; Vasodilator Agents | 1994 |
Effect of replacing the aspartic acid/glutamic acid residues of bullfrog sialic acid binding lectin with asparagine/glutamine and arginine on the inhibition of cell proliferation in murine leukemia P388 cells.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Arginine; Asparagine; Aspartic Acid; Cell Division; Circular Dichroism; Cloning, Molecular; Escherichia coli; Glutamic Acid; HL-60 Cells; Humans; Lectins; Leukemia P388; Mice; Microscopy, Fluorescence; Mutagenesis, Site-Directed; N-Acetylneuraminic Acid; Rana catesbeiana; Ribonucleases | 2002 |
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.
Topics: Adenocarcinoma; Animals; Cell Survival; Colonic Neoplasms; Etoposide; Humans; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Podophyllotoxin; Skin Ulcer; Solvents; Teniposide; Tumor Stem Cell Assay | 1983 |
Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
Topics: Amsacrine; Animals; Base Sequence; Binding Sites; DNA; DNA Topoisomerases, Type II; DNA, Viral; Electrophoresis, Agar Gel; Idarubicin; Leukemia P388; Mice; Mitoxantrone; Molecular Sequence Data; Mutagenesis; Oligodeoxyribonucleotides; Simian virus 40; Substrate Specificity; Teniposide; Tumor Cells, Cultured | 1993 |
Evidence of DNA topoisomerase II-dependent mechanisms of multidrug resistance in P388 leukemia cells.
Topics: Adenosine Triphosphate; Animals; Cell Nucleus; DNA; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Leukemia P388; Mice; Plasmids; Teniposide; Tumor Cells, Cultured | 1990 |
Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity.
Topics: Amsacrine; Animals; Antibiotics, Antineoplastic; Base Sequence; Daunorubicin; DNA, Viral; Doxorubicin; Leukemia P388; Mice; Molecular Sequence Data; Molecular Structure; Simian virus 40; Stereoisomerism; Structure-Activity Relationship; Teniposide; Topoisomerase II Inhibitors | 1990 |